NervGen Pharma Corp. a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that the company has granted 950,000.
Vancouver, British Columbia (Newsfile Corp. - June 6, 2024) - Sanatana Resources Inc. (TSXV: STA) ("Sanatana" or the "Company") is pleased to announce that, further to its news release of May 7, 2024
Vancouver, British Columbia (Newsfile Corp. - June 6, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) a clinical-stage biotech company dedicated to developing innovative solutions for the treatment
CARLYLE COMMODITIES CORP. is pleased to announce it intends to complete a non-brokered private placement of up to 15,000,000 units at a price of $0.04 per Unit for aggregate gross proceeds of up.
Vancouver, British Columbia (Newsfile Corp. - June 6, 2024) - China Keli Electric Company Ltd. (NEX: ZKL.H) (the "Company" or "China Keli") announces that its common shares will be reinstated for trading